Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

June 12, 2023 10:46 (London Time)

Moderna

Youtube Subscribe

...

Sector: Biotechnology
Ticker: MRNA
Sentiment: -0.9891
MarketCap: 46,987,863,371.0
High: 125.63 Low: 122.8

Open: 124.7 Close: 123.26 Change: -1.44

The 12 top things that an AI found about Moderna and you do not know…

How much time have you spent trying to decide whether investing in Moderna? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, vaccine, …

Concept Map

...

Semantic Network

...

Stock Summary

Moderna, Inc. discovers, develops, and commercializes messenger RNA therapeutics and vaccines. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV.

Today's Summary

Moderna Therapeutics CEO Stéphane Bancel had previously stated that developing an mpox vaccine was not of high priority. Recent uptick might appease Moderna, Inc. institutional owners after losing 4.8% over the past year.

Today's News

Moderna and Mercks experimental cancer vaccine, used in combination with Merck s Keytruda, reduced the risk of melanoma spreading to other parts of the body or death by 65% in patients with stage 3 or 4 of the disease compared with patients who received Mercks immunotherapy treatment alone. Moderna Therapeutics (NASDAQ: MRNA) is a biotechnology company that is focused on drug discovery and drug development based on messenger RNA. The lawsuits add to a web of patent disputes between biotech companies over technology used in coronavirus shots. Moderna Therapeutics CEO Stéphane Bancel had previously stated that developing an mpox vaccine was not of high priority. The forthcoming trials exemplify the agility of Modernas mRNA platform. Moderna (NASDAQ:MRNA) closed at $124.94, marking a -0.53% move from the previous day. With a volume of 2,635,886, the price of MRNA is down -1.01% at $129.19. Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. Recent uptick might appease Moderna, Inc. institutional owners after losing 4.8% over the past year. Moderna, Pfizer and BioNTech accused of infringing a patent related to messenger RNA technology. Pfizer earned $37.8 billion from sales of its COVID-19 vaccine Comirnaty last year, while Moderna made $18.4 billion from its vaccine Spikevax. Moderna (MRNA) stock is sinking this morning despite positive Phase 2b data on its mRNA cancer vaccine yesterday. Moderna and Merck said Monday that their cancer shot mRNA-4157 (V940), with Keytruda cut the risk cancer metastasis or death in melanoma. Moderna qualifies a clinical trial as diverse when: 37% of the sample population within the U.S. Moderna has now had 18 clinical trials that have been an estimated 40% diverse. Moderna is using mobile care centers to reach remote communities and people who might have challenges with transportation. The Moderna vaccine provides protection against COVID-19 for at least six months after the second dose. The most common side effects of the Moderna Vaccine include pain and swelling at the injection site. STI Awareness Week is April 9 th – 15 th. The Prince William Health District clinics and mobile clinic unit will no longer offer doses of the Moderna monovalent primary series. The Pfizer-BioNTech, Moderna, Johnson & Johnson/Janssen and Novavax COVID-19 vaccines will continue to undergo the most intensive safety monitoring in US history. The Prince William Health District Mobile Clinic Unit Offering Bivalent Booster Vaccine. Theres a nationwide shortage with the new (bivalent) Moderna COVID booster vaccine. Pfizer and Moderna Bivalent COVID-19 vaccines are offered at the PHPC vaccine clinic. The university highly recommends that all faculty, staff and students get vaccinated.

Stock Profile

"Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts."

Keywords

Are looking for the most relevant information about Moderna? Investor spend a lot of time searching for information to make investment decisions in Moderna. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, vaccine, cancer, MRNA, COVID19, use, trial, and the most common words in the summary are: vaccine, moderna, covid19, stock, pfizer, best, last, . One of the sentences in the summary was: institutional owners after losing 4.8% over the past year.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #vaccine #moderna #covid19 #stock #pfizer #best #last.

Read more →

Related Results

...
March 07, 2024 1:50 (London Time)

Moderna

Moderna-stock Moderna Inc stock , MRNA 97.99 -0.11% After-market 07:59:34 PM NAS Start Trading.
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9871
MarketCap: 36,518,557,220.0
High: 98.41 Low: 95.58

Open: 96.38 Close: 98.1 Change: 1.72

Read more →
...
February 21, 2024 0:02 (London Time)

Moderna

Moderna Inc. stock underperformed compared to its competitors in a recent trading session. The efficacy of Modernas RSV vaccine appears to wane fast…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.8779
MarketCap: 33,694,066,726.0
High: 89.53 Low: 86.48

Open: 87.36 Close: 86.99 Change: -0.37

Read more →
...
January 23, 2024 2:10 (London Time)

Moderna

Moderna inc. stock continues steady m Monday, underperforming market. CEO Stephane Bancel says his company has a lot of innovation in the pipeline t…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.979
MarketCap: 38,012,107,981.0
High: 102.97 Low: 98.6

Open: 100.25 Close: 99.7 Change: -0.55

Read more →
...
December 30, 2023 19:55 (London Time)

Moderna

Walgreens, Nike, Moderna: Bargain hunting stocks. Moderna (MRNA) closed at $99.45, marking a +0.67% move from the previous day. Wall Street is expec…
Sector: Biotechnology
Ticker: MRNA
Sentiment: -0.8291
MarketCap: 37,926,319,082.0
High: 100.8 Low: 98.02

Open: 98.61 Close: 99.45 Change: 0.84

Read more →
...
November 19, 2023 4:22 (London Time)

Moderna

Moderna Inc. stock fell friday, underperforms market - marketwatch.com. Moderna Therapeutics is a biotechnology company that focuses on the developm…
Sector: Biotechnology
Ticker: MRNA
Sentiment: -0.4138
MarketCap: 29,145,348,654.0
High: 77.42 Low: 74.78

Open: 77.15 Close: 76.44 Change: -0.71

Read more →
...
October 04, 2023 22:51 (London Time)

Moderna

Moderna hopes to get approval for a combined flu vaccine by 2025. The two-in-one vaccine also appeared to have a similar safety profile.
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9756
MarketCap: 39,239,095,822.0
High: 104.82 Low: 99.33

Open: 104.61 Close: 104.26 Change: -0.35

Read more →
...
September 03, 2023 4:07 (London Time)

Moderna

CEO and Director Stephane Bancel made the largest insider sale of Moderna in last year. Pfizer and Moderna vaccines are fully FDA approved and the N…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.6697
MarketCap: 42,839,501,705.0
High: 114.72 Low: 111.57

Open: 114.21 Close: 112.56 Change: -1.65

Read more →
...
August 23, 2023 20:21 (London Time)

Moderna

Moderna COVID-19 vaccine, now called Spikevax, is now available for people 18 and older. Moderna has lost more than 40 percent of its market value t…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9341
MarketCap: 42,276,224,675.0
High: 117.68 Low: 111.85

Open: 117.34 Close: 115.46 Change: -1.88

Read more →
...
August 15, 2023 14:45 (London Time)

Moderna

Moderna, Pfizer, and Novavax plan to release updated vaccines this fall. Draft CDC vaccine recommendations presented in June would allow for a singl…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.856
MarketCap: 38,059,258,800.0
High: 98.88 Low: 96.67

Open: 98.73 Close: 97.01 Change: -1.72

Read more →
...
July 28, 2023 10:45 (London Time)

Moderna

Ark Investment Management continued to load up on shares of COVID-19 vaccine maker Moderna, Inc. Ark through its Ark Genomic Revolution ETF (CBOE: A…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.6486
MarketCap: 45,177,119,001.0
High: 122.14 Low: 118.25

Open: 121.5 Close: 118.51 Change: -2.99

Read more →
...
July 07, 2023 7:16 (London Time)

Moderna

Moderna closed at $123.54 in the latest trading session, marking a +1.49% move from the prior day. Moderna is holding a Zacks Rank of #3 (Hold) righ…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9022
MarketCap: 45,093,252,946.0
High: 123.27 Low: 117.11

Open: 122.51 Close: 118.29 Change: -4.22

Read more →
...
June 25, 2023 15:41 (London Time)

Moderna

Moderna (MRNA) closed the most recent trading day at $128.73, moving -0.96% from the previous trading session. Pfizer and Moderna on track to delive…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9729
MarketCap: 45,173,306,908.0
High: 120.12 Low: 117.23

Open: 119.7 Close: 118.5 Change: -1.2

Read more →
...
June 12, 2023 22:54 (London Time)

Moderna

Moderna (MRNA) closed at $124.94, marking a -0.53% move from the previous day. Pfizer earned $37.8 billion from sales of its COVID-19 vaccine Comirn…
Sector: Biotechnology
Ticker: MRNA
Sentiment: -0.7992
MarketCap: 46,987,863,371.0
High: 123.87 Low: 121.56

Open: 123.36 Close: 123.52 Change: 0.16

Read more →
...
May 25, 2023 19:09 (London Time)

Moderna

Moderna Therapeutics (NASDAQ: MRNA) is a biotechnology company that is focused on drug discovery and drug development based on messenger RNA. The Pf…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.2023
MarketCap: 51,808,119,695.0
High: 130.16 Low: 126.0

Open: 130.0 Close: 126.45 Change: -3.55

Read more →
...
May 14, 2023 7:01 (London Time)

Moderna

Moderna Therapeutics raised a total of $1.961B in 2013. Moderna was criticized earlier this spring for planning to raise its vaccine price. Pfizer a…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.6124
MarketCap: 51,808,119,695.0
High: 131.06 Low: 128.05

Open: 128.5 Close: 129.3 Change: 0.8

Read more →
...
February 28, 2024 2:15 (London Time)

Moderna

Moderna stock jumped 7% during premarket trading on Thursday after the pharma company reported a profit of $217 million in its fourth quarter ending…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9709
MarketCap: 35,922,523,016.0
High: 97.47 Low: 92.58

Open: 94.31 Close: 96.2 Change: 1.89

Read more →
...
February 18, 2024 15:35 (London Time)

Moderna

Covid-19 vaccine maker Moderna said 2023 product sales hit $6.7 billion, above the companys guidance, but down 60% from 2022. Moderna believes messe…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.1331
MarketCap: 33,694,066,726.0
High: 90.85 Low: 87.37

Open: 90.41 Close: 88.37 Change: -2.04

Read more →
...
January 20, 2024 2:03 (London Time)

Moderna

Moderna CoVID-19 vaccine is an mRNA vaccine produced by the American company Moderna. Company raised $2   billion in venture capital funding between…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9394
MarketCap: 37,773,805,483.0
High: 100.44 Low: 97.08

Open: 98.43 Close: 99.7 Change: 1.27

Read more →
...
December 10, 2023 20:17 (London Time)

Moderna

Moderna has been named a top biopharmaceutical employer by Science for the past eight years. European Patent Office has invalidated one of Modernas …
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.5106
MarketCap: 30,620,917,718.0
High: 81.82 Low: 78.76

Open: 79.16 Close: 80.32 Change: 1.16

Read more →
...
November 19, 2023 0:54 (London Time)

Moderna

Moderna Therapeutics is a biotechnology company that focuses on the development of messenger RNA (mRNA) therapeutics and vaccines. Moderna came into…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.6597
MarketCap: 29,145,348,654.0
High: 77.42 Low: 74.78

Open: 77.15 Close: 76.44 Change: -0.71

Read more →
...
September 06, 2023 8:02 (London Time)

Moderna

UK drug regulator approves updated COVID-19 vaccine by Pfizer and its German partner BioNTech that targets only XBB.1.5 subvariant of the virus. Mod…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.8258
MarketCap: 42,839,501,705.0
High: 112.78 Low: 108.99

Open: 112.72 Close: 109.36 Change: -3.36

Read more →
...
August 28, 2023 3:14 (London Time)

Moderna

Updated Covid shots are expected this fall from Pfizer, Moderna and Novavisax. Pfizer and Moderna are brewing doses of the XBB update.
Sector: Biotechnology
Ticker: MRNA
Sentiment: -0.1027
MarketCap: 42,599,728,374.0
High: 114.7 Low: 109.81

Open: 113.65 Close: 111.93 Change: -1.72

Read more →
...
August 22, 2023 18:31 (London Time)

Moderna

Moderna, Pfizer, Novavax, BioNTech and others developing versions aimed at XBB 1.5, a close relative. Moderna is advancing messenger RNA science to …
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9413
MarketCap: 42,276,224,675.0
High: 116.0 Low: 112.47

Open: 112.5 Close: 115.67 Change: 3.17

Read more →
...
August 08, 2023 23:05 (London Time)

Moderna

Moderna expects $6 billion to $8 billion in sales for its Covid shot this year, up from $5 billion. Moderna, Pfizer and Novavax have all seen a stee…
Sector: Biotechnology
Ticker: MRNA
Sentiment: -0.2939
MarketCap: 38,515,969,905.0
High: 101.82 Low: 98.86

Open: 101.36 Close: 99.74 Change: -1.62

Read more →
...
July 23, 2023 17:09 (London Time)

Moderna

Moderna closed at $124.77 in the latest trading session, marking a -0.32% move from the prior day. Moderna is holding a Zacks Rank of #3 (Hold) righ…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.9403
MarketCap: 48,196,296,982.0
High: 127.22 Low: 121.61

Open: 125.73 Close: 126.43 Change: 0.7

Read more →
...
June 30, 2023 11:53 (London Time)

Moderna

Moderna (MRNA) closed at $123, marking a +1.93% move from the previous day. Bernie Sanders promised to grill Moderna CEO in a Senate hearing next mo…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.891
MarketCap: 46,000,531,178.0
High: 122.98 Low: 121.3

Open: 122.5 Close: 122.11 Change: -0.39

Read more →
...
June 14, 2023 11:39 (London Time)

Moderna

Moderna (MRNA) closed at $124.94, marking a -0.53% move from the previous day. Moderna sued Pfizer and BioNTech in 2022, claiming that the companies…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.5267
MarketCap: 48,787,171,461.0
High: 128.84 Low: 122.9

Open: 123.25 Close: 127.98 Change: 4.73

Read more →
...
June 12, 2023 10:46 (London Time)

Moderna

Moderna Therapeutics CEO Stéphane Bancel had previously stated that developing an mpox vaccine was not of high priority. Recent uptick might appease…
Sector: Biotechnology
Ticker: MRNA
Sentiment: -0.9891
MarketCap: 46,987,863,371.0
High: 125.63 Low: 122.8

Open: 124.7 Close: 123.26 Change: -1.44

Read more →
...
May 19, 2023 1:06 (London Time)

Moderna

Moderna (MRNA) stock is sinking this morning despite positive Phase 2b data on its mRNA cancer vaccine. MRNA stock is on the heels of positive resul…
Sector: Biotechnology
Ticker: MRNA
Sentiment: -0.7934
MarketCap: 51,808,119,695.0
High: 126.0 Low: 122.99

Open: 125.92 Close: 125.33 Change: -0.59

Read more →
...
April 30, 2023 20:26 (London Time)

Moderna

Moderna failed to persuade a Delaware federal judge to shift liability from the company to the U.S. government for alleged patent infringement by Mo…
Sector: Biotechnology
Ticker: MRNA
Sentiment: 0.7672
MarketCap: 51,252,752,384
High: 133.26 Low: 129.02

Open: 130.04 Close: 132.89 Change: 2.85

Read more →